Catheter-based closure of the patent foramen ovale

Circulation

Volumn 120, Issue 18, 2009, Pages 1837-1841

  Meier, Bernhard ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CONTRAST MEDIUM; WARFARIN;

ADULT; AIR EMBOLISM; CARDIOVASCULAR EQUIPMENT; CASE REPORT; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; ELECTROCARDIOGRAM; EMBOLISM; FEMALE; HEART CATHETERIZATION; HUMAN; PATENT FORAMEN OVALE; PRIORITY JOURNAL; REVIEW; THROMBOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MYOCARDIAL ISCHEMIA; THROMBOEMBOLISM;

EID: 70449482411     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.903427     Document Type: Review

References (25)

1. Fukumoto A, Yaku H, Doi K, Ito H, Numata S, Hayashida K, Inoue T, Akabame S, Oda Y, Matsubara H, Nishimura T. Images in cardiovascular medicine: continuous thrombus in the right and left atria penetrating the patent foramen ovalles. Circulation. 2005;112: e143-e144.
2. Weber F, Goriup A. Prevalence of right-to-left shunts in active fighter pilots. Aviat Space Environ Med. 2007;78:135-136.
3. Parsons FG, Keith A. Seventh report of the Committee of Collective Investigation of the Anatomical Society of Great Britain and Ireland, 1896-1897. J Anat Physiol. 1897;32: 164-186.
4. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17-20.
5. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148-1152.
6. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL. Patent foramen ovale in young stroke patients. Lancet. 1988;2:11-12.
7. Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol. 1992;70:668-672.
8. Van Camp G, Schulze D, Cosyns B, Van-denbossche JL. Relation between patent foramen ovale and unexplained stroke. Am J Cardiol. 1993;71:596-598.
9. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991;151: 933-938.
10. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation. 2003; 107:5-9. (Pubitemid 36070923)
11. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126: 483S-512S.
12. Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, Kasner SE. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1042-1050. (Pubitemid 38456495)
13. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with is-chemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37: 577-617. (Pubitemid 43732031)
14. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
15. Soerensen H, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboem-bolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet. 2007;370: 1773-1779.
16. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation. 1998;97: 1946-1951.
17. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect: nonop-erative closure during cardiac catheteriza-tion. JAMA. 1976;235:2506-2509.
18. Gruentzig AR. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978; 1:263.
19. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcath-eter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86:1902-1908.
20. Wahl A, Meier B. Patent foramen ovale and ventricular septal defect closure. Heart. 2009;95:70-82.
21. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004; 43:302-309. (Pubitemid 38201160)
22. Wahl A, Praz F, Stirnimann J, Windecker S, Seiler C, Nedeltchev K, Mattle HP, Meier B. Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients. Swiss Med Wkly. 2008;138:567-572.
23. O'Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2009;53:2014-2018.
24. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryp-togenic stroke. J Am Coll Cardiol. 2004;44: 750-758. (Pubitemid 39099567)
25. Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol. 2005;101:77-82.